NCT03082040

Brief Summary

This is a prospective, triple-blinded and randomized controlled trial examining the effects of a home-based breathing training assisted with biofeedback on menopausal symptoms and autonomic functions among community menopausal women. We also examines whether the changes in autonomic functions would be mediators between slow breathing and menopausal symptoms. This study will include menopausal women, aged from 45 to 64, who experienced menopausal symptoms. Participants will be randomly assigned to either an intervention group (n = 80) or a waiting-list control group (n = 80). The intervention group will undergo the home-based breathing training 20 minutes twice daily and participants in the control condition will participate the same breathing training after a four-week waiting list period. The primary outcome measures are menopausal symptoms measured by symptom diaries of menopausal symptoms and the Greene Climacteric Scale (GCS). Secondary outcome measures are autonomic functions expressed by blood pressure (BP), heart rate (HR) and heart rate variability (HRV). Measurements will be taken at baseline, week 4, and week 8.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 26, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 17, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2017

Completed
Last Updated

June 5, 2020

Status Verified

June 1, 2020

Enrollment Period

1.2 years

First QC Date

March 6, 2017

Last Update Submit

June 4, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Menopausal symptoms

    Assessments using the Greene Climacteric Scale (GCS) for self-reported menopausal symptoms

    Baseline

  • Menopausal symptoms

    Assessments using the Greene Climacteric Scale (GCS) for self-reported menopausal symptoms

    Posttest (4 weeks from baseline)

Secondary Outcomes (6)

  • Autonomic functions (Blood pressure)

    Baseline

  • Autonomic functions (Blood pressure)

    Posttest (4 weeks from baseline)

  • Autonomic functions (heart rate)

    Baseline

  • Autonomic functions (heart rate)

    Posttest (4 weeks from baseline)

  • Autonomic functions (heart rate variability)

    Baseline

  • +1 more secondary outcomes

Study Arms (2)

intervention group

EXPERIMENTAL

The intervention group will undergo a home-based breathing training 20 minutes twice daily for four weeks

Behavioral: home-based breathing training

waiting-list control group

OTHER

Participants in the control condition will conduct the same breathing training as the intervention group after a four-week waiting list period

Behavioral: home-based breathing training

Interventions

The intervention group will undergo a home-based breathing training 20 minutes twice daily for four weeks. Participants in the control condition will participate the same breathing training after a four-week waiting list period.

intervention groupwaiting-list control group

Eligibility Criteria

Age45 Years - 64 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • aged from 45 to 64, reporting cessation of menstrual cycles with natural causes ≧ 12 consecutive months
  • the Greene Climacteric Scale (GCS) Chinese version scores ≧ 1

You may not qualify if:

  • clinically diagnosed with history of cardiac arrhythmia, coronary heart disease, heart failure, kidney disease, hypertension, chronic low blood pressure, diabetic neuropathy, psychosis or mental deficiency
  • received hormone replacement therapy prescribed by gynecological physicians
  • took cardiac medications which may affect the autonomic functions, ex., β-blockers, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fu Jen Catholic University

New Taipei City, Xinzhuang Dist, 24205, Taiwan

Location

Study Officials

  • Yuh-Kae Shyu, PhD

    Fu Jen Catholic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 6, 2017

First Posted

March 17, 2017

Study Start

October 26, 2016

Primary Completion

December 20, 2017

Study Completion

December 20, 2017

Last Updated

June 5, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations